Hepatobiliary and pancreatic disease
Conditions
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years, no gender limit; 2. Patients who have been judged by the researchers to need hepatobiliary pancreatectomy; 3. No other anti-tumor therapy or immunotherapy was performed before surgery; 4. No history of other malignant tumors; 5. Able to cooperate with and complete follow-up and related examinations; 6. Voluntarily participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating patients; 2. Severe coagulation dysfunction, obvious bleeding tendency (platelets < 100x10^9 /L); 3. History of major abdominal surgery; 4. Accompanied by failure of important organs and inability to tolerate general anesthesia; 5. Multiple organ resection requirements (additional surgical removal of surrounding solid organs); 6. Combined with surgical site or systemic infection, severe inflammatory reaction; 7. Patients who have not completed clinical trials of other investigational drugs or devices; 8. Patients considered unsuitable for this project by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful operation;Urinalysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time;Rate of negative margins;Number of lymph nodes dissected;Time to first flatus after operation;Time to first feeding after operation;Hospital stay; | — |
Countries
China
Contacts
Public ContactTian Xiaodong
Peking University First Hospital
Outcome results
None listed